boehringer ingelheim glp-1 Pipeline Snapshot: Next-Gen Therapies Emerge | BioKnow posted on the topic Hair loss with GLP-1 drugs

And this study was quite large as far as studies go

Mahendragarh, Sausar, Ponneri, Mahad, Lohardaga, Tirwaganj, Margherita, Sundarnagar, Rajgarh, Mangaldoi, Renigunta, Longowal, Ratia, Lalgudi, Shrirangapattana, Niwari, Natham, Unnamalaikadai, PurqUrban Agglomerationzi, Shamsabad, Farrukhabad, Mirganj, Todaraisingh, Warhapur, Rajam, Urmar Tanda, Lonar, Powayan, P.N.Patti, Palampur, Srisailam Project (Right Flank Colony) Township, Sindagi, Sandi, Vaikom, Malda, Tharangambadi

Broad Therapeutic Effects : Tirzepatide results in clinically significant improvements in multiple obesity-related complications, including sleep apnea, metabolic dysfunction-associated steatohepatitis, heart failure with preserved ejection fraction, and diabetes prevention [79]

J Neurosci Res 79:509521 Aureli T, Miccheli A, Di Cocco ME, Ghirardi O, Giuliani A, Ramacci MT, Conti F (1994) Effect of acetyl-l-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the ratstudy by 13P- and 1H-NMR spectroscopy

Noom offers cut-price compounded GLP-1 drug for obesity Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US